Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats
- PMID: 1432160
Comparison of technetium-99m-glucarate and thallium-201 for the identification of acute myocardial infarction in rats
Abstract
The scintigraphic identification of acute severe ischemic myocardial injury requires a marker that localizes rapidly and specifically in zones of damaged myocardium. Technetium-99m-glucarate, a six-carbon dicarboxylic acid, which behaves in vivo somewhat like fructose, was recently described as a marker of severe acute ischemic injury with necrosis. This study was performed to determine the interval between the onset of myocardial ischemia and initial uptake and the duration of a positive scan in experimental animals. Serial injections and images were recorded over 10 days following ligation of the left anterior descending coronary artery of the rat. The distribution of 99mTc-glucarate was compared to that of regional myocardial perfusion monitored with 201TI. The findings on radionuclide imaging were compared to histologic changes in the myocardium. Sequential pinhole images of both radionuclides were collected at 3 hr, 24 hr, 72 hr and 7-10 days following ligation. Ten rats had normal 201TI distributions, no uptake of glucarate and no evidence of infarction by TTC staining at autopsy. Twenty-one rats had either 201TI lesions or evidence of infarction at autopsy. In 17 of these rats, significant acute 99mTc-glucarate uptake was noted, decreasing at 24 hr, and was not seen at 72 hr or 7-10 days. The extent of perfusion abnormality was greatest at 3 hr in most animals; the lesion decreased in four (33%), increased in one (8%) and remained stable in the remainder. These data suggest that 99mTc-glucarate may be a useful marker of acute myocardial injury.
Similar articles
-
Distribution of deoxyglucose and technetium-99m-glucarate in the acutely ischemic myocardium.J Nucl Med. 1993 Aug;34(8):1303-8. J Nucl Med. 1993. PMID: 8326389
-
Localization of technetium-99m-glucarate in zones of acute cerebral injury.J Nucl Med. 1991 Feb;32(2):272-8. J Nucl Med. 1991. PMID: 1704054
-
Early detection of infarct in reperfused canine myocardium using 99mTc-glucarate.J Nucl Med. 2004 Apr;45(4):655-64. J Nucl Med. 2004. PMID: 15073263
-
New possibilities in scintigraphy detection of carbon monoxide cardiotoxicity.Przegl Lek. 2001;58(4):182-4. Przegl Lek. 2001. PMID: 11450331 Review.
-
Non-invasive in vivo imaging of myocardial apoptosis and necrosis.Eur J Nucl Med Mol Imaging. 2003 Apr;30(4):615-30. doi: 10.1007/s00259-003-1136-y. Epub 2003 Mar 14. Eur J Nucl Med Mol Imaging. 2003. PMID: 12638039 Review.
Cited by
-
(99m)Tc-glucarate imaging for the early detection of infarct in partially reperfused canine myocardium.Eur J Nucl Med Mol Imaging. 2006 Mar;33(3):319-28. doi: 10.1007/s00259-005-1913-x. Epub 2005 Oct 20. Eur J Nucl Med Mol Imaging. 2006. PMID: 16237571
-
Indium 111 antimyosin and Tc-99m glucaric acid for noninvasive identification of oncotic and apoptotic myocardial necrosis.J Nucl Cardiol. 2002 Sep-Oct;9(5):471-81. doi: 10.1067/mnc.2002.124479. J Nucl Cardiol. 2002. PMID: 12360127
-
99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1909-17. doi: 10.1007/s00259-010-1495-0. Epub 2010 Jul 24. Eur J Nucl Med Mol Imaging. 2010. PMID: 20652807
-
Progression of detail.J Nucl Cardiol. 2000 Mar;7(2):177-9. doi: 10.1016/S1071-3581(00)90041-2. J Nucl Cardiol. 2000. PMID: 27517559 No abstract available.
-
Differentiation of myocardial ischemia and necrosis by technetium 99m glucaric acid kinetics.J Nucl Cardiol. 1997 Jul-Aug;4(4):274-82. doi: 10.1016/s1071-3581(97)90104-5. J Nucl Cardiol. 1997. PMID: 9278873
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical